Evidence map›Paper›PMID 26824653›Full record

ArticleCell2016

Trim28 Haploinsufficiency Triggers Bi-stable Epigenetic Obesity.

Kevin Dalgaard, Kathrin Landgraf, Steffen Heyne, Adelheid Lempradl, John Longinotto, Klaus Gossens, Marius Ruf, Michael Orthofer, Ruslan Strogantsev, Madhan Selvaraj and 20 more

Open access · hybridAbstract read
In one paragraph

Article in Cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed
16.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 195 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. MidbrainbioRxiv : the preprint server for biology · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Professor Emma Whitelaw, a pioneer of epigenetic inheritance.Frontiers in epigenetics and epigenomics · 2025
    Article
  15. Article
  16. Multifaceted role ofMedComm · 2024
    Review
  17. Review
  18. Article
  19. Article
  20. Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors at 9 institutions in 7 countries.

Kevin DalgaardMax Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
Kathrin LandgrafDepartment of Women's and Child Health, Center for Pediatric Research Leipzig, University Hospital for Children & Adolescents, University of Leipzig, 04103 Leipzig, Germany; Integrated Research and Treatment Center (IFB) Adiposity Diseases, University of Leipzig, 04103 Leipzig, Germany.
Steffen HeyneMax Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
Adelheid LempradlMax Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
John LonginottoMax Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
Klaus GossensMax Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
Marius RufMax Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
Michael OrthoferIMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences,1030 Vienna, Austria.
Ruslan StrogantsevDepartment of Genetics, University of Cambridge, Cambridge CB2 3EH, UK.
Madhan SelvarajMax Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
Tess Tsai-Hsiu LuMax Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
Eduard CasasInstitute for Predictive and Personalized Medicine of Cancer (IMPPC) and Josep Carreras Leukaemia Research Institute, Can Ruti Campus, Ctra de Can Rutí, Cami de les Escoles s/n, Badalona 08916, Barcelona, Spain.
Raffaele TeperinoMax Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
M Azim SuraniWellcome Trust Cancer Research UK Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK; Department of Physiology, Development and Neuroscience, University of Cambridge, Downing Street, Cambridge CB2 3EG, UK; Wellcome Trust-MRC Stem Cell Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 3EG, UK.
Ilona ZvetkovaUniversity of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Welcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
Debra RimmingtonUniversity of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Welcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
Y C Loraine TungUniversity of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Welcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
Brian LamUniversity of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Welcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
Rachel LarderUniversity of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Welcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
Giles S H YeoUniversity of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Welcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
Stephen O'RahillyUniversity of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Welcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
Tanya VavouriInstitute for Predictive and Personalized Medicine of Cancer (IMPPC) and Josep Carreras Leukaemia Research Institute, Can Ruti Campus, Ctra de Can Rutí, Cami de les Escoles s/n, Badalona 08916, Barcelona, Spain.
Emma WhitelawDepartment of Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Melbourne, VIC 3086, Australia.
Josef M PenningerIMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences,1030 Vienna, Austria.
Thomas JenuweinMax Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
Ching-Lung CheungDepartment of Pharmacology and Pharmacy, Centre for Genomic Sciences, The University of Hong Kong, Hong Kong.
Anne C Ferguson-SmithDepartment of Genetics, University of Cambridge, Cambridge CB2 3EH, UK.
Anthony P CollUniversity of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Welcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
Antje KörnerDepartment of Women's and Child Health, Center for Pediatric Research Leipzig, University Hospital for Children & Adolescents, University of Leipzig, 04103 Leipzig, Germany; Integrated Research and Treatment Center (IFB) Adiposity Diseases, University of Leipzig, 04103 Leipzig, Germany.
J Andrew PospisilikMax Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany. Electronic address: pospisilik@ie-freiburg.mpg.de.
Max Planck Institute of Immunobiology and Epigenetics · DEUniversity of Cambridge · GBAddenbrooke's Hospital · GBIFB Adiposity Diseases · DEJosep Carreras Leukaemia Research Institute · ESAustrian Academy of Sciences · ATChinese University of Hong Kong · CNInstitute of Molecular Biotechnology · ATLa Trobe University · AU

Funding

Transgenic CoreP30DK057521 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI FLOREZ, JOSE CARLOS · 2000 to 2019
$31.4M
Medical Research Council G0600717Medical Research Council G0900554Medical Research Council MC_PC_12009Medical Research Council MC_UU_12012/1Medical Research Council MC_UU_12012/5Medical Research Council MR/J001597/1Medical Research Council MR/L00027X/1NIDDK NIH HHS P30 DK057521Wellcome Trust 095515/Z/11/ZWellcome Trust 095606
6 · The paper itself

Abstract

More than one-half billion people are obese, and despite progress in genetic research, much of the heritability of obesity remains enigmatic. Here, we identify a Trim28-dependent network capable of triggering obesity in a non-Mendelian, "on/off" manner. Trim28(+/D9) mutant mice exhibit a bi-modal body-weight distribution, with isogenic animals randomly emerging as either normal or obese and few intermediates. We find that the obese-"on" state is characterized by reduced expression of an imprinted gene network including Nnat, Peg3, Cdkn1c, and Plagl1 and that independent targeting of these alleles recapitulates the stochastic bi-stable disease phenotype. Adipose tissue transcriptome analyses in children indicate that humans too cluster into distinct sub-populations, stratifying according to Trim28 expression, transcriptome organization, and obesity-associated imprinted gene dysregulation. These data provide evidence of discrete polyphenism in mouse and man and thus carry important implications for complex trait genetics, evolution, and medicine.

Indexed as

Epigenesis, GeneticHaploinsufficiencyAdolescentAnimalsBody Mass IndexChildChild, PreschoolHumansMiceNuclear ProteinsNutrition SurveysObesityPolymorphism, GeneticRepressor ProteinsThinnessTripartite Motif-Containing Protein 28Nuclear ProteinsRepressor ProteinsTRIM28 protein, humanTrim28 protein, mouseTripartite Motif-Containing Protein 28

Identifiers

PMID26824653
PMCPMC4735019
OpenAlexW2254116509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.